Dr. Robert Malone (mRNA vaccine inventor) on Ivermectin, Escape Mutants, and the Faulty Logic of Vaccine Mandates (Highly Informative, Rational Video Interview)
Posted by freedomforall 2 years, 7 months ago to Science
Highly informative and rational interview. I recommend it!
Notes:
American Thought Leaders takes a closer look at repurposed drugs like ivermectin and how a universal vaccination policy could actually backfire—and bring about the emergence of vaccine-resistant escape mutants.
At their core, vaccine mandates are not just unethical and divisive, but also “impractical and unnecessary,” says Dr. Malone.
Below is a list of references mentioned or related to the discussion in this episode:
“Ivermectin for preventing and treating COVID-19” — The Cochrane Database of Systematic Reviews
“Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019” — Chest Journal
“Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” — American Journal of Therapeutics
“Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” — Clinical Therapeutics
“Dexamethasone in Hospitalized Patients with Covid-19” — The New England Journal of Medicine
“ACTIV-6: COVID-19 Study of Repurposed Medications” — NIH
“Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals” — Cell Reports
“Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization” — Nature
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (Note: This is a preprint)
“Mutation rate of COVID-19 virus is at least 50 percent higher than previously thought” — Phys.org
“Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants” — The New England Journal of Medicine
“Why is the ongoing mass vaccination experiment driving a rapid evolutionary response of SARS-CoV-2?” — Trial Site News
“The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape” (Note: This is a preprint)
“The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines” (Note: This is a preprint)
“Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens” — PLOS Biology
“Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant” (Note: This is a preprint).
“Fauci: Amount of virus in breakthrough delta cases ‘almost identical’ to unvaccinated” — The Hill
CDC: “Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021”
“Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California” (Note: This is a preprint)
“New delta variant studies show the pandemic is far from over” — ScienceNews
“Read: Internal CDC document on breakthrough infections” — The Washington Post
“New UCSF study: Vaccine-resistant viruses are driving ‘breakthrough’ COVID infections” — The Mercury News
“Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” (Note: This is a preprint)
“Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital” — Science
“Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint)
“SARS-CoV-2 variants of concern and variants under investigation in England” — Public Health England
“Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting” — The New England Journal of Medicine
“Real-World Study Captures Risk of Myocarditis With Pfizer Vax” — MedPage Today
CDC: “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020—August 2021”
“CDC: Covid-19 Vaccine Effectiveness Fell From 91% To 66% With Delta Variant“ — Forbes
“SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans” — Nature
“Causes and consequences of purifying selection on SARS-CoV-2” — Genome Biology and Evolution
“The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus” — Journal of Travel Medicine
“Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint)
---------------------------------------
Notes:
American Thought Leaders takes a closer look at repurposed drugs like ivermectin and how a universal vaccination policy could actually backfire—and bring about the emergence of vaccine-resistant escape mutants.
At their core, vaccine mandates are not just unethical and divisive, but also “impractical and unnecessary,” says Dr. Malone.
Below is a list of references mentioned or related to the discussion in this episode:
“Ivermectin for preventing and treating COVID-19” — The Cochrane Database of Systematic Reviews
“Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019” — Chest Journal
“Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” — American Journal of Therapeutics
“Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” — Clinical Therapeutics
“Dexamethasone in Hospitalized Patients with Covid-19” — The New England Journal of Medicine
“ACTIV-6: COVID-19 Study of Repurposed Medications” — NIH
“Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals” — Cell Reports
“Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization” — Nature
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (Note: This is a preprint)
“Mutation rate of COVID-19 virus is at least 50 percent higher than previously thought” — Phys.org
“Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants” — The New England Journal of Medicine
“Why is the ongoing mass vaccination experiment driving a rapid evolutionary response of SARS-CoV-2?” — Trial Site News
“The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape” (Note: This is a preprint)
“The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines” (Note: This is a preprint)
“Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens” — PLOS Biology
“Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant” (Note: This is a preprint).
“Fauci: Amount of virus in breakthrough delta cases ‘almost identical’ to unvaccinated” — The Hill
CDC: “Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021”
“Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California” (Note: This is a preprint)
“New delta variant studies show the pandemic is far from over” — ScienceNews
“Read: Internal CDC document on breakthrough infections” — The Washington Post
“New UCSF study: Vaccine-resistant viruses are driving ‘breakthrough’ COVID infections” — The Mercury News
“Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” (Note: This is a preprint)
“Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital” — Science
“Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint)
“SARS-CoV-2 variants of concern and variants under investigation in England” — Public Health England
“Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting” — The New England Journal of Medicine
“Real-World Study Captures Risk of Myocarditis With Pfizer Vax” — MedPage Today
CDC: “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020—August 2021”
“CDC: Covid-19 Vaccine Effectiveness Fell From 91% To 66% With Delta Variant“ — Forbes
“SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans” — Nature
“Causes and consequences of purifying selection on SARS-CoV-2” — Genome Biology and Evolution
“The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus” — Journal of Travel Medicine
“Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint)
---------------------------------------
I have been listening to Dr Malone.